KAR-1880

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKAR-1880
Drug Alias Nameanti-inflammatory OS-HDIHDAC 2 Inhibitors (Karus)OS-HDI-2KAR-1880
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2
Therapy Area/IndicationsPsoriasisDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarus Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKarus Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitis

Other Information

ATC CodeN/A
Related LinksN/A